InsidersTradesSigma
Novozymes A/S Stock: price and management transactions · Denmark · Finanstilsynet DK
Follow the Novozymes A/S stock price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares are listed on DK DK, under the authority of Finanstilsynet DK. Operating in the Chemicals sector, Novozymes A/S has published 88 reports. The latest transaction was disclosed on 6 May 2026 (Purchase). Among the most active insiders: Unknown. Every trade is openly available.
88
Insider Decl.
0
Thresholds
€18m
69 ops.
Buy Volume
€112,275
5 ops.
Sell Volume
14Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 May 2026
Declarations88 total
2,500 shares@ DKK 393.69160.6% of flowShareOMX CopenhagenDK:1440144
Ideal exit: 31 Jan 2027 (T+270)
400 shares@ DKK 371.800.1% of flowShareNasdaq CopenhagenDK:1429237
4 shares@ DKK 3.000.0% of flowShareXCSEDK:1428126
Ideal exit: 18 Dec 2026 (T+270)
725 shares@ DKK 347.400.2% of flowShareNasdaqDK:1425698
1,500 shares@ DKK 368.100.3% of flowShareUBS SIDK:1423171
2,700 shares@ DKK 371.98020.6% of flowShareOMX CopenhagenDK:1422930
18,337 shares@ DKK 368.504.2% of flowShareOutside a trading venueDK:1422788
2,500 shares@ DKK 397.07160.6% of flowShareNasdaqDK:1402016
Ideal exit: 18 Aug 2026 (T+270)
380 shares@ DKK 418.100.1% of flowShareNasdaq XCSEDK:1399510
Ideal exit: 4 Aug 2026 (T+270)
ShareOutside a trading venueDK:1398579
48,610 shares@ DKK 286.09068.6% of flowShareOutside a trading venueDK:1386700
Ideal exit: 30 May 2026 (T+270)
2,000 shares@ DKK 396.22920.5% of flowShare- Turquoise EuropeDK:1385800
Ideal exit: 25 May 2026 (T+270)
2,000 shares@ DKK 396.22920.5% of flowShare- Turquoise EuropeDK:1385794
Ideal exit: 25 May 2026 (T+270)
716 shares@ DKK 390.000.2% of flowShareNasdaq CopenhagenDK:1384879
Ideal exit: 19 May 2026 (T+270)
3,000 shares@ DKK 398.490.7% of flowShareOMX CopenhagenDK:1384811
Ideal exit: 19 May 2026 (T+270)
34,407 shares@ DKK 350.807.5% of flowShareOutside a trading venueDK:1368228
Ideal exit: 7 Mar 2026 (T+270)
19,934 shares@ DKK 249.403.1% of flowShareOutside a trading venueDK:1362576
Ideal exit: 6 Feb 2026 (T+270)
1,000 shares@ DKK 402.41460.2% of flowShareXCSEDK:1351471
Ideal exit: 21 Dec 2025 (T+270)
26,550 shares@ DKK 249.404.1% of flowShareOutside a trading venueDK:1347415
Ideal exit: 1 Dec 2025 (T+270)
1,000 shares@ DKK 439.500.3% of flowShareXCSEDK:1347062
Ideal exit: 30 Nov 2025 (T+270)
1,620 shares@ DKK 425.300.4% of flowShareXCSEDK:1346494
12,120 shares@ DKK 428.103.2% of flowShareOutside a trading venueDK:1345683
ShareOutside a trading venueDK:1335997
Share- Cboe Europe Equities - European Equities (Nl)DK:1328947
Ideal exit: 17 Aug 2025 (T+270)
ShareOutside a trading venueDK:1325508
25 of 88 declarations
About Novozymes A/S
Novozymes A/S is a Danish biotechnology company that provides enzymatic solutions for various sectors, including agriculture and food. It is listed on the Copenhagen Stock Exchange under the symbol NOVOZ.
